NASDAQ: CDT
Conduit Pharmaceuticals Inc Stock Ownership - Who owns Conduit Pharmaceuticals?

Insider buying vs selling

Have Conduit Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew ReganChief Executive Officer2025-06-03154,799$3.23
$500.00kBuy
Faith L. CharlesDirector2025-04-16115,194$0.87
$99.99kBuy
Freda C. LewishallDirector2025-03-3047,612$0.89
$42.37kBuy
Faith L. CharlesDirector2025-03-3046,629$0.89
$41.50kBuy
Chele Chiavacci FarleyDirector2025-03-3032,022$0.89
$28.50kBuy
Simon Jeremy FryDirector2025-03-3029,354$0.89
$26.13kBuy
Faith L. CharlesDirector2024-11-18266,594$0.09
$24.53kBuy
Chele Chiavacci FarleyDirector2024-11-18299,238$0.09
$27.53kBuy
Freda C. LewishallDirector2024-11-18437,976$0.09
$40.29kBuy
Nirland Ltd10% Owner2024-10-07939,009$0.10
$96.72kSell

1 of 3

CDT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CDT insiders and whales buy or sell their stock.

CDT Shareholders

What type of owners hold Conduit Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew Regan5,709.25%45,527,311$110.18MInsider
Nirland Ltd763.95%6,092,000$14.74MInsider
Jack Kendrick Heilbron598.08%4,769,250$11.54MInsider
David Tapolczay251.22%2,003,324$4.85MInsider
Sarborg Ltd232.49%1,853,933$4.49MInsider
Murphy Canyon Acquisition Sponsor LLC94.55%754,000$1.82MInsider
Shaolin Capital Management LLC77.37%616,950$1.49MInsider
Freda C. Lewishall72.00%574,147$1.39MInsider
Faith L. Charles20.72%165,238$399.88kInsider
Aqr Capital Management LLC13.96%111,355$269.48kInstitution

1 of 3

CDT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CDT0.82%99.18%Net SellingNet Buying
PTIX57.35%7.78%
ALZN0.18%99.82%Net BuyingNet Selling
TNFA1.39%51.39%
SLRX0.55%99.45%

Conduit Pharmaceuticals Stock Ownership FAQ

Who owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals (NASDAQ: CDT) is owned by 64.49% institutional shareholders, 7,832.69% Conduit Pharmaceuticals insiders, and 0.00% retail investors. Andrew Regan is the largest individual Conduit Pharmaceuticals shareholder, owning 45.53M shares representing 5,709.25% of the company. Andrew Regan's Conduit Pharmaceuticals shares are currently valued at $112.00M.

If you're new to stock investing, here's how to buy Conduit Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.